Purchase Order 36C24224P1640
- Not listed
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract worth $344,084.80 to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. This order is not part of a set-aside program. Illumina will provide microarray kits to support genomic sequencing and analysis for research and diagnostics purposes at the agency. Illumina has previously provided a range of sequencing instruments,...
- The Department of Veterans Affairs Veterans Health Administration awarded a $115,442.10 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract does not have a set-aside designation. Illumina will provide DNA array processing services to support research and diagnostic applications at the VA's Palo Alto, California facility. Illumina is an experienced federal contractor, having provided sequencing systems,...
- This federal contract award to Illumina, Inc., a manufacturer of sequencing and genomic analysis equipment and reagents, was issued by the Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 6. The $131,328.00 firm fixed price purchase order is for the delivery of Illumina assays and reagents to support genomic sequencing and analysis. This award does not have a set-aside designation. Illumina has a history of providing sequencing systems,...
- This is a firm fixed price delivery order awarded to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, by the Veterinary Services division of the U.S. Department of Veterans Affairs. The $10,463.01 contract is for the provision of Illumina's sequencing instruments, reagents, consumables, and maintenance services, which support critical genomic research and diagnostic initiatives across various federal agencies. Illumina holds two notable Indefinite...
- The Department of Veterans Affairs (VA) awarded a $272,276.80 firm fixed-price delivery order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of microarray kits, with a performance period ending on February 6, 2020. Illumina has a history of providing sequencing systems, reagents, and services to support genomic research and diagnostics across various federal agencies, including the NIH, CDC,...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, to provide GLOBAL DIVERSITY ARRAY KITS. The $161,481.60 award has a completion date of December 28, 2021 and was made on December 29, 2020. Illumina has previously received prime federal contracts from agencies such as the NIH, CDC, USDA, and VA to provide a range of sequencing systems, reagents, and services to...
- This is a federal contract award to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract, valued at $83,920.86, is a Firm Fixed Price Purchase Order from the Department of Veterans Affairs (VA), a civilian agency. The contract is not set aside and is for the provision of micro arrays. Illumina has been awarded multiple federal contracts and Indefinite Delivery Vehicles (IDVs), including a $45 million contract with the U.S....
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $497,245.96, is for the provision of Illumina's genomic sequencing services and related products, including sequencing instruments like NextSeq, NovaSeq, and MiSeq systems, along with associated reagents, consumables, maintenance, and technical support. The contract does not...
- This is a federal contract award to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, for the delivery of various DNA sequencing products and services. The award, valued at $20,294.92, is a delivery order under Illumina's existing contracts with the Department of Veterans Affairs (VA), specifically a Blanket Purchase Agreement valued at $231,165 and an Indefinite Delivery Contract valued at $1,297,062. The contract covers the procurement of...
- This is a federal contract award to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, by the U.S. Department of Veterans Affairs (VA). The contract has a ceiling value of $22,274.30 and is a Blanket Purchase Agreement (BPA) call order, with a firm fixed price pricing type. The contract does not have a set-aside designation. Illumina is providing the VA with a range of its advanced sequencing instruments, reagents, consumables, and bioinformatics...
The Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a $203,798.14 firm fixed-price purchase order to Illumina, Inc. on August 6, 2024, for Illumina reagents modification with an ultimate completion date of August 1, 2025. The award carries no set-aside designation and represents a direct procurement from Illumina, the San Diego-based biotechnology leader in genetic sequencing and genomic analysis technologies. This purchase order supports the VA's genomic research and diagnostic capabilities, leveraging Illumina's specialized reagent products that are essential components of next-generation sequencing workflows used across federal research and healthcare initiatives. Illumina maintains an extensive federal contracting portfolio with the VA and numerous other agencies, including a substantial $45 million Indefinite Delivery/Indefinite Quantity contract with the U.S. Department of Agriculture that extends through June 2030. The company's federal presence reflects its position as a foundational technology provider for genomic research, with awards spanning the National Institutes of Health, National Cancer Institute, Food and Drug Administration, and Department of Defense agencies. As a sole-source provider of proprietary sequencing systems and associated consumables, Illumina's contracts typically employ firm fixed-price structures without competitive set-asides, underscoring the specialized nature of its genomic sequencing solutions within the federal market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | ($8k) | 2/26/26 | |
| P00001 | Additional Work (new agreement, FAR part 6 applies) | ($190) | 9/2/25 | |
| Not listed | Not listed | $212.4k | 9/12/24 |